FDA DrugClass IINotable
FDA Recall: Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmace
Description
Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
Hazard
Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
Remedy
675 bottles
Related Recalls
2026-08-12 · FDA_DRUG
FDA Recall: Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesci
Zydus Pharmaceuticals (USA) Inc
2026-08-12 · FDA_DRUG
FDA Recall: Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pha
Aurobindo Pharma USA Inc
2026-08-12 · FDA_DRUG
FDA Recall: Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: L
Sunny Pharmtech Inc.
2026-08-12 · FDA_DRUG
FDA Recall: Cyclophosphamide for Injection, USP, 1 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: L
Sunny Pharmtech Inc.